Burden of Disease in Stage IV Non-Small Cell Lung Cancer: Comparing ALK Positive and ALK Negative Mutation Status in Egypt, Russia and the United Arab Emirates
Value Health
.
2014 Nov;17(7):A618.
doi: 10.1016/j.jval.2014.08.2183.
Epub 2014 Oct 26.
Authors
M Fisher
1
,
J De Renteria
2
,
M Kuehl
3
,
S Suponcic
4
,
K Dharamshi
1
Affiliations
1
FIECON, London, UK.
2
Kantar Health, Munich, Germany.
3
Kantar Health, Epsom, UK.
4
Kantar Health, New York, NY, USA.
PMID:
27202172
DOI:
10.1016/j.jval.2014.08.2183
No abstract available